» Articles » PMID: 14573770

Common Signaling Pathways Link Activation of Murine PAR-1, LPA, and S1P Receptors to Proliferation of Astrocytes

Overview
Journal Mol Pharmacol
Date 2003 Oct 24
PMID 14573770
Citations 102
Authors
Affiliations
Soon will be listed here.
Abstract

Receptors for the serine protease thrombin and for lysophospholipids are coupled to G proteins and control a wide range of cellular functions, including mitogenesis. Activators of these receptors are present in blood, and can enter the brain during central nervous system (CNS) injury. Reactive astrogliosis, a prominent component of CNS injury with potentially harmful consequences, may involve proliferation of astrocytes. In this study, we have examined the expression and activation of protease activated receptors (PARs), lysophosphatidic acid (LPA) receptors, and sphingosine-1-phosphate (S1P) receptors on murine astrocytes. We show that activation of these three receptor classes can lead to astrogliosis in vivo and proliferation of astrocytes in vitro. Cultured murine cortical astrocytes express mRNA for multiple receptor subtypes of PAR (PAR-1-4), LPA (LPA-1-3) and S1P (S1P-1, -3, -4, and -5) receptors. Comparison of the intracellular signaling pathways of glial PAR-1, LPA, and S1P receptors indicates that each receptor class activates multiple downstream signaling pathways, including Gq/11-directed inositol lipid/Ca2+ signaling, Gi/o activation of mitogen-activated protein kinases (MAPK) (extracellular signal-regulated kinase 1/2 and stress activated protein kinase/c-jun N-terminal kinase, but not p38), and activation of Rho pathways. Furthermore, activation of these different receptor classes can differentially regulate two transcription factor pathways, serum response element and nuclear factor of activated T cells. Blockade of Gi/o signaling with pertussis toxin, MAPK activation with 1,4-diamino-2,3-dicyano-1,4-bis(2-aminophynyltio)butadiene (U0126), or Rho kinase signaling with R-(+)-trans-N-(4-pyridyl)-4-(1-aminoethyl)-cyclohexane carboxamide (Y27632) can markedly reduce the proliferative response of glial cells to PAR-1, LPA, or S1P receptor activation, suggesting that each of these pathways is important in coupling of receptor activation to glial proliferation.

Citing Articles

Activation of the Coagulation Cascade as a Universal Danger Sign.

Starikova E, Mammedova J, Rubinstein A, Sokolov A, Kudryavtsev I Curr Issues Mol Biol. 2025; 47(2).

PMID: 39996829 PMC: 11854423. DOI: 10.3390/cimb47020108.


Blood-Brain Barrier Disruption in Neuroimmunological Disease.

Shimizu F, Nakamori M Int J Mol Sci. 2024; 25(19).

PMID: 39408955 PMC: 11476930. DOI: 10.3390/ijms251910625.


The compartment-specific manipulation of the NAD/NADH ratio affects the metabolome and the function of glioblastoma.

Lee M, Yoo J, Kim I, Kang S, Lee W, Kim S Sci Rep. 2024; 14(1):20575.

PMID: 39232046 PMC: 11375122. DOI: 10.1038/s41598-024-71462-8.


G protein-biased LPAR1 agonism of prototypic antidepressants: Implication in the identification of novel therapeutic target for depression.

Kajitani N, Okada-Tsuchioka M, Inoue A, Miyano K, Masuda T, Boku S Neuropsychopharmacology. 2023; 49(3):561-572.

PMID: 37673966 PMC: 10789764. DOI: 10.1038/s41386-023-01727-9.


Emerging Roles of Lysophosphatidic Acid in Macrophages and Inflammatory Diseases.

Jiang S, Yang H, Li M Int J Mol Sci. 2023; 24(15).

PMID: 37569902 PMC: 10419859. DOI: 10.3390/ijms241512524.